文献速递肿瘤 PET/CT核素与放射性配体治疗

定义前列腺癌患者机器人辅助[99mTc]Tc-PSMA放射引导手术中识别阳性淋巴结的最佳靶本比:一项前瞻性II期研究的更新结果和中期分析

Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-06-11

该中期分析纳入30例有病理信息的前列腺癌患者,术前行PSMA PET,术中使用γ探针进行[99mTc]Tc-PSMA-I&S放射引导手术。结果显示靶本比≥2时区域灵敏度72%、特异度88%、准确率87%,可识别PSMA PET未发现的阳性病灶,并可能豁免超过50%的扩大盆腔淋巴结清扫。

要点

  • 靶本比≥2识别可疑淋巴结可豁免超过50%的扩大盆腔淋巴结清扫。
  • 靶本比≥2区域灵敏度72%、特异度88%、准确率87%,优于靶本比≥3和≥4。
  • 靶本比≥2可发现PSMA PET未检测到的8个可疑区域,其中5个含淋巴结侵犯。

核心结论

  • 使用靶本比≥2识别可疑淋巴结的PSMA放射引导手术可豁免超过50%的扩大盆腔淋巴结清扫,并较PSMA PET和更高靶本比识别更多pN1患者。

研究设计与样本

  • 前瞻性II期研究的中期分析,聚焦30例有可用病理信息的患者。
  • 所有患者术前行PSMA正电子发射断层扫描(PET),术前一天给予[99mTc]Tc-PSMA-I&S,术中使用γ探针进行体内测量。

主要发现

  • 总体9例(30%)患者存在淋巴结侵犯,阳性区域22个(13%),阳性淋巴结80个(11%)。
  • PSMA放射引导手术在靶本比≥2、≥3、≥4时分别于12例(40%)、7例(23%)、6例(20%)患者中显示摄取。
  • 区域水平靶本比≥2 vs ≥3 vs ≥4的灵敏度分别为72% vs 54% vs 36%,特异度分别为88% vs 98% vs 99%,准确率分别为87% vs 92% vs 91%。
  • 仅对PSMA PET可疑斑点患者(n=7)行扩大盆腔淋巴结清扫可豁免77%的扩大盆腔淋巴结清扫,但遗漏13%(n=3)的pN1患者。
  • 放射引导手术靶本比≥2识别出8个(24%)PSMA PET未检测到的可疑区域,其中5个(63%)存在淋巴结侵犯,1例pN1患者(11%)会被PSMA PET遗漏。

关键数值与推荐

  • 靶本比≥2定义为放射引导手术阳性阈值,区域灵敏度72%、特异度88%、准确率87%。

临床怎么用

  • 作者结论认为,使用靶本比≥2识别可疑淋巴结的PSMA放射引导手术可豁免超过50%的扩大盆腔淋巴结清扫,并较PSMA PET和更高靶本比识别更多pN1患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Prostate-specific membrane antigen radioguided surgery (PSMA-RGS) might identify lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing extended pelvic lymph node dissection (ePLND). The optimal target-to-background (TtB) ratio to define RGS positivity is still unknown. MATERIALS & METHODS: Ad interim analyses which focused on 30 patients with available pathological information were conducted. All patients underwent preoperative PSMA positron emission tomography (PET). 99m-Technetium-PSMA imaging and surgery ([99mTc]Tc-PSMA-I&S) was administered the day before surgery. In vivo measurements were conducted using an intraoperative gamma probe. Performance characteristics and implications associated with different TtB ratios were assessed. RESULTS: Overall, 9 (30%) patients had LNI, with 22 (13%) and 80 (11%) positive regions and lymph nodes, respectively. PSMA-RGS showed uptakes in 12 (40%) vs. 7 (23%) vs. 6 (20%) patients for a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4. At a per-region level, sensitivity, specificity and accuracy for a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4 were 72%, 88% and 87% vs. 54%, 98% and 92% vs. 36%, 99% and 91%. Performing ePLND only in patients with suspicious spots at PSMA PET (n = 7) would have spared 77% ePLNDs at the cost of missing 13% (n = 3) pN1 patients. A TtB ratio ≥ 2 at RGS identified 8 (24%) suspicious areas not detected by PSMA PET, of these 5 (63%) harbored LNI, with one pN1 patient (11%) that would have been missed by PSMA PET. Adoption of a TtB ratio ≥ 2 vs. ≥ 3 vs. ≥ 4, would have allowed to spare 18 (60%) vs. 23 (77%) vs. 24 (80%) ePLNDs missing 2 (11%) vs. 3 (13%) vs. 4 (17%) pN1 patients. CONCLUSIONS: PSMA-RGS using a TtB ratio ≥ 2 to identify suspicious nodes, could allow to spare > 50% ePLNDs and would identify additional pN1 patients compared to PSMA PET and higher TtB ratios.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Quarta L, Mazzone E, Cannoletta D, et al. Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study. Eur J Nucl Med Mol Imaging. 2024. PMID: 38861182. doi:10.1007/s00259-024-06789-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。